Renal dysfunction (CrCl <50 mL/min) or severe hepatic impairment (Child-Pugh C) — limits...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-PROSTATE-ORGAN-DYSFUNCTION |
|---|---|
| Type | Red flag |
| Status | pending_clinical_signoff |
| Diseases | DIS-PROSTATE |
| Sources | SRC-ESMO-PROSTATE-2024 SRC-NCCN-PROSTATE-2025 |
Red Flag Origin
| Definition | Renal dysfunction (CrCl <50 mL/min) or severe hepatic impairment (Child-Pugh C) — limits PARPi (olaparib renal-cleared) and ARPI (abiraterone hepatic) dosing. |
|---|---|
| Clinical direction | investigate |
| Category | organ-dysfunction |
Trigger Logic
{
"any_of": [
{
"comparator": "<",
"finding": "creatinine_clearance_ml_min",
"threshold": 50
},
{
"finding": "child_pugh_class",
"value": "C"
}
],
"type": "composite_clinical"
}
Notes
Olaparib requires CrCl ≥31 (with dose-mod) for safe use; <30 avoid. Abiraterone Child-Pugh C: avoid. Surfaces in MDT as need for renal/ hepatic input.
Used By
Indications
IND-PROSTATE-MCRPC-1L-ARPI- IND-PROSTATE-MCRPC-1L-ARPIIND-PROSTATE-MCRPC-1L-PARPI- IND-PROSTATE-MCRPC-1L-PARPIIND-PROSTATE-MCRPC-2L-CABAZITAXEL- IND-PROSTATE-MCRPC-2L-CABAZITAXELIND-PROSTATE-MCRPC-2L-DOCETAXEL- IND-PROSTATE-MCRPC-2L-DOCETAXELIND-PROSTATE-MCRPC-2L-LU-PSMA- IND-PROSTATE-MCRPC-2L-LU-PSMAIND-PROSTATE-MCRPC-2L-RADIUM223- IND-PROSTATE-MCRPC-2L-RADIUM223IND-PROSTATE-MHSPC-1L-ARPI-DOUBLET- IND-PROSTATE-MHSPC-1L-ARPI-DOUBLETIND-PROSTATE-MHSPC-1L-TRIPLET- IND-PROSTATE-MHSPC-1L-TRIPLET